In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
David Hyman and Robin Gillespie
Finding
#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
A scientist holding a tube in a lab
Sloan Kettering Institute Year in Review: 10 Noteworthy Science Breakthroughs of 2021

Take a look back at some of the biggest science stories from this past year.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
A scientist pipetting in a lab
MSK Research Highlights, March 9, 2023

New research from MSK offers new proof-of-concept compounds against acute myeloid leukemia; reports results from a phase 1 clinical trial appraising two drugs against low- grade glioma; examines MSK’s first-in-the-nation program integrating herbal medicine into oncology care; and identifies how high-grade histologic patterns in lymph node metastases could better predict lung cancer outcomes.
Pictured: X-ray Image
In the Lab
New Findings Clarify How Kidney Cancer Spreads to Distant Organs

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
woman against grey background with her head in her hands
Feature
Coping with Shame Related to Cancer

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously

Learn how a blood test could someday provide a way to detect cancers at an early stage.
Surgeon William Jarnagin
Finding
Experimental Blood Test Uses EVP Proteins to Detect Cancer

Researchers report a new method that may enable detection of a number of different types of cancer in the early stages.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
Promising Results from the First-Ever Trial of a Drug that Blocks Cancer Gene KRAS

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.